Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay.

scientific article

Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10096-014-2211-Y
P698PubMed publication ID25082186

P50authorElisabetta BlasiQ54196302
Massimo GirardisQ57080256
Carlotta F OrsiQ59662392
P2093author name stringF Forghieri
C Venturelli
F Luppi
P Pini
C Bettua
L Faglioni
S Bigliardi
P2860cites workInvasive aspergillosis in critically ill patients without malignancyQ80269940
Galactomannan detection for invasive aspergillosis in immunocompromized patientsQ24240734
Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humansQ28265703
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012Q28284276
Invasive aspergillosis in the intensive care unitQ28306909
Evaluation of PCR for detection of DNA specific for Aspergillus species in sera of patients with various forms of pulmonary aspergillosis.Q33685971
Factors associated with mortality in transplant patients with invasive aspergillosisQ33867013
Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimensQ34190354
Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosisQ34385038
Evaluation of MycAssay™ Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancerQ34688953
Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive AspergillosisQ35066867
Evaluation of Aspergillus PCR protocols for testing serum specimensQ35530598
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassayQ35599066
Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.Q35668212
Invasive fungal infections in patients with hematologic malignancies (aurora project): lights and shadows during 18-months surveillanceQ35719482
Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1-->3)-beta-D-glucan antigensQ36900157
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/Q37164067
Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysisQ37380385
Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samplesQ39990268
Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.Q40419516
Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008).Q44020369
International study of the prevalence and outcomes of infection in intensive care unitsQ44988294
Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignanciesQ45286729
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 updateQ46050924
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassayQ46503389
Performance of 2 commercial real-time polymerase chain reaction assays for the detection of Aspergillus and Pneumocystis DNA in bronchoalveolar lavage fluid samples from critical care patientsQ46960195
Pulmonary aspergillosis: early diagnosis improves survivalQ70877231
P433issue1
P304page(s)131-136
P577publication date2014-08-01
P1433published inEuropean Journal of Clinical Microbiology & Infectious DiseasesQ15754378
P1476titleClinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay
P478volume34

Reverse relations

cites work (P2860)
Q49307735Diagnostic Modalities for Invasive Mould Infections among Hematopoietic Stem Cell Transplant and Solid Organ Recipients: Performance Characteristics and Practical Roles in the Clinic
Q52689844Evaluation of Two Commercial Real-Time PCR Kits for Aspergillus DNA Detection in Bronchoalveolar Lavage Fluid in Patients with Invasive Pulmonary Aspergillosis.
Q40948260Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
Q90429595Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response
Q37363385Molecular Diagnostic Testing for Aspergillus
Q54217644Overview of Commercially Available PCR Assays for the Detection of Aspergillus spp. DNA in Patient Samples.
Q49245587PCR Technology for Detection of Invasive Aspergillosis
Q51511753Quantitative Real-Time PCR and Platelia Galactomannan Assay for the Diagnosis of Invasive Pulmonary Aspergillosis: Bronchoalveolar Lavage Fluid Performs Better Than Serum in Non-neutropaenic Patients.

Search more.